CAUTION: In Europe, the ACURATE neo2 Aortic Valve System is CE-marked. In the USA, the ACURATE neo2 Valve and the ACURATE Prime Aortic Valve System XL are investigational devices and restricted under federal law to investigational use only. Not available for sale.
The ACURATE neo2™ Aortic Valve System is the next iteration of the ACURATE neo™ Aortic Valve System. It features Active PVseal™ technology and an extended sealing skirt to cover the full waist of the stent, a radiopaque positioning marker designed to give a clear visual reference for easy and accurate positioning, and extra wide stabilization arches to facilitate coronary access. The ACURATE neo2 Valve received CE mark in April 2020.
History of ACURATE
The ACURATE Valve has been implanted in more than 60,000 patients across more than 50 countries globally. More than 2,400 patients have been included in past clinical research.